Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)
- Status
- COMPLETED
- Phase
- N/A
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Alvocidib Biomarker-driven Phase 2 AML Study
- Status
- TERMINATED
- Phase
- PHASE2
IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
BL-8040 Addition to Consolidation Therapy in AML Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
- Status
- COMPLETED
- Phase
- PHASE2
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant
- Status
- COMPLETED
- Phase
- PHASE1
A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients
- Status
- SUSPENDED
- Phase
- PHASE2
Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML
- Status
- COMPLETED
- Phase
- PHASE3